Proxima Supper Series

​🍽️ The Proxima Supper Series brings together 10-14 senior healthcare leaders for an intimate, off-the-record dinner conversation you won't find anywhere else.

​🔬 When Every Lab Has a Model: A Supper Series Dinner with Guido Lanza

​🤖 This year OpenAI released a reasoning model built for life sciences, Anthropic opened a wet lab and signed a drug discovery collaboration with Novo Nordisk, and Alphabet’s Isomorphic Labs raised $2.1 billion. The frontier labs are no longer just selling tools to drug discovery. They are starting to do it.

​🔮 So where does that leave the companies that have spent years building AI drug discovery platforms? Guido Lanza, SVP and Chief Technology Officer at Valo Health, has been building machine learning for drug design since 2001. Valo’s position is that the defensible asset is not the model but the data and the lab: longitudinal records on more than 20 million patients and engineered human tissue to test against. We’ll get into whether that holds as general-purpose models get better at biology, and what it means for pharma partners now working with both.

​✅ Space is limited. RSVP today to secure your seat.